4.3 Microbiologic Diagnostics: Deep Tissue Curettage vs. Superficial Swabs, Bone Biopsy, and Culture Interpretation

The Wound Bioburden Continuum and Culture Indications

All open cutaneous wounds, including every diabetic foot ulcer, harbor microorganisms on their surface. The mere isolation of bacteria from an ulcer does not establish an active infection. Clinical practice requires distinguishing between the stages of the microbial bioburden continuum:

1. Contamination: The presence of non-replicating microorganisms deposited on the wound surface from external environmental sources. No host cellular reaction occurs, and wound healing is unaffected.
2. Colonization: Microorganisms attach to the wound surface and successfully replicate, forming stable colonies without causing host cellular injury or inducing an immune response. Colonizing flora often exist in a dynamic commensal balance.
3. Critical Colonization (Local Infection): Microorganisms multiply to concentrations exceeding host tissue defenses, often organizing into protective biofilms. While classical overt signs of spreading infection (erythema, warmth, purulence) are absent, subtle clinical indicators appear: delayed healing, friable or hyper-granulation tissue that bleeds easily on contact, pocketing of the wound base, increased serous exudate, and foul odor.
4. Invasive Infection (True Tissue Infection): Microorganisms penetrate and multiply within viable, living sub-epidermal tissues, triggering a host inflammatory response characterized by the classical signs of infection: erythema, warmth, edema, localized pain or tenderness, and purulent drainage.

The Clinical Mandate: When to Culture (and When Not To)

Fundamental Practice Rule: Clinical cultures must ONLY be obtained when objective clinical signs of infection are present.

Culturing a clean, non-infected, granulating diabetic foot ulcer violates core antimicrobial stewardship principles. Culturing uninfected wounds inevitably recovers harmless surface colonizers, prompting inappropriate prescription of broad-spectrum antibiotics, escalating adverse drug reactions, and accelerating the emergence of multi-drug resistant organisms (MDROs).

---

Pitfalls of Superficial Swab Cultures

Commensal Flora vs. Invasive Tissue Pathogens

Routine superficial swabbing of an uncleaned, undebrided ulcer bed represents one of the most pervasive and dangerous diagnostic errors in wound care:

• Superficial Skin Flora: The intact stratum corneum and superficial necrotic debris are heavily colonized by commensal organisms, including coagulase-negative staphylococci (Staphylococcus epidermidis), Corynebacterium species (diphtheroids), Cutibacterium acnes, and Micrococcus species. These organisms rarely cause invasive diabetic foot infections.
• Diagnostic Discordance: Comparative clinical trials demonstrate a discordance exceeding 70% between superficial swab results and paired deep tissue curettage specimens from the same ulcer. A superficial swab frequently isolates superficial commensals while failing to detect the true virulent pathogens—such as Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas aeruginosa, or obligate anaerobes—burrowing deep within the advancing tissue margin.

The Modified Levine Technique (When Swabs Are Unavoidable)

When institutional limitations or patient factors make tissue biopsy or curettage impossible, a swab must be performed strictly using the Levine technique, rather than random surface swiping:

1. Thoroughly debride all superficial necrotic eschar, loose slough, and overlying biofilm.
2. Irrigate the ulcer vigorously with sterile, nonbacteriostatic $0.9\%$ saline.
3. Identify a $1\text{-cm}^2$ area of clean, viable, non-necrotic granulation tissue near the center of the wound.
4. Press the tip of a sterile culture swab firmly against this $1\text{-cm}^2$ zone with sufficient downward force to express clean wound fluid from the deep tissue.
5. Rotate the swab $360^\circ$ while maintaining continuous pressure to absorb the expressed interstitial fluid.

---

Standardized Soft Tissue Sampling Techniques

To ensure accurate, actionable microbiological results, clinicians must collect viable deep tissue specimens using aseptic surgical technique.

                 STANDARDIZED TISSUE SAMPLING PROTOCOL

   Step 1: Surgical Debridement
   Excise superficial eschar, nonviable slough, and overlying biofilm
                 │
                 ▼
   Step 2: Vigorous Saline Irrigation
   Rinse copiously with nonbacteriostatic sterile 0.9% saline
   (NEVER apply topical antiseptics immediately prior to sampling)
                 │
                 ▼
   Step 3: Deep Tissue Acquisition
   Scrape viable tissue from ulcer base using sterile dermal curette
   OR perform 3-mm to 4-mm punch biopsy of viable margin
                 │
                 ▼
   Step 4: Immediate Anaerobic/Aerobic Transport
   Place in pre-reduced transport medium; deliver to lab within 30-60 min

Step-by-Step Deep Tissue Curettage Protocol

1. Debridement: Using a sterile scalpel (e.g., #15 or #10 blade), aggressively debride all nonviable surface tissue, thick hyperkeratotic callus, and necrotic slough.
2. Irrigation: Copiously irrigate the wound bed with sterile, nonbacteriostatic $0.9\%$ saline to wash away residual debris, surface planktonic bacteria, and dressing residue.
   • Antiseptic Prohibition: Never apply topical antiseptic agents (e.g., povidone-iodine, chlorhexidine gluconate, sodium hypochlorite/Dakin's solution, acetic acid) immediately prior to culture collection. Antiseptics leave bactericidal chemical residues that kill viable organisms in the specimen, yielding false-negative culture results.
3. Curettage: Using a sterile dermal curette (e.g., 3-mm or 4-mm round or oval curette), firmly scrape the active, viable ulcer base or advancing wound margin until minute punctate bleeding occurs. Collect the tissue scrapings directly into a sterile container.
4. Punch Biopsy: Alternatively, a sterile 3-mm or 4-mm punch biopsy tool is rotated perpendicularly through viable tissue at the advancing ulcer margin, excised at the subcutaneous base with tissue forceps and iris scissors, and submitted for culture and histology.
5. Aspiration of Closed Collections: If fluctuance, bullae, or an intact subcutaneous abscess is present, aspirate the fluid using a sterile 18- to 20-gauge needle and 5-mL syringe through intact, chlorhexidine-prepped skin. Never aspirate through an open, contaminated wound defect.
6. Laboratory Transport: Immediately place tissue fragments into an anaerobic and aerobic transport container (such as a pre-reduced port-a-cul vial). Deliver the specimen to the microbiology laboratory within 30 to 60 minutes to ensure the viability of fastidious obligate anaerobes.

---

Bone Biopsy: The Diagnostic Gold Standard for Osteomyelitis

Bone culture with histopathology is the criterion reference when definitive pathogen and tissue diagnosis is needed in diabetic foot osteomyelitis (DFO), but biopsy is selected according to diagnostic uncertainty, feasibility, and treatment consequences.

Histopathological and Microbiological Superiority

Imaging studies (plain radiography, MRI, nuclear scans) demonstrate morphological and metabolic changes, but they cannot identify the specific causative bacterial pathogen or its antimicrobial resistance profile. Bone biopsy fulfills both critical requirements:

• Histology: Confirms osteomyelitis by identifying osteonecrosis, marrow infiltration by polymorphonuclear leukocytes (acute DFO) or plasma cells/lymphocytes (chronic DFO), osteolysis, and empty osteocyte lacunae.
• Microbiology: Isolates the true intraosseous pathogens, enabling definitive narrowing of antimicrobial therapy to targeted, narrow-spectrum agents.

Percutaneous Biopsy: The Uninfected Skin Corridor

To prevent introducing superficial colonizers into the bone sample, percutaneous bone biopsy must follow a rigorous procedural protocol:

• Route of Entry: The biopsy needle or trochar (e.g., Jamshidi needle) must NEVER pass through an open ulcer bed, sinus tract, or infected soft tissue. Passing a needle through an open wound contaminates the sterile bone sample with surface bacteria, producing a false-positive result.
• Technique: The clinician identifies a trajectory through intact, uninfected skin overlying the target bone. The skin is scrubbed with chlorhexidine gluconate, allowed to dry completely, and anesthetized locally. The trochar is advanced percutaneously to the bone cortex, penetrates the cortex with a twisting motion, and extracts an intact core of bone marrow and trabeculae.
• Specimen Allocation: One bone core is submitted in a sterile container for quantitative/qualitative aerobic, anaerobic, and fungal culture; a second core is placed in $10\%$ buffered formalin for histopathological staining (hematoxylin-eosin and Gram stain).

Antibiotic Exposure Before Bone Biopsy

Prior antibiotics can reduce culture yield, but the optimal antibiotic-free interval is unknown. If the patient is stable, the multidisciplinary team may consider a brief delay based on infection risk, prior therapy, and biopsy access. Do not delay needed antibiotics or source control in a progressing or systemic infection.

---

Microbial Spectrum and Culture Interpretation

Diabetic foot infections encompass a spectrum of microbiological architectures dictated by chronicity, ulcer depth, prior antimicrobial exposure, and tissue ischemia.

Acute, Superficial, Treatment-Naive DFIs

In patients presenting with an acute, superficial ulcer who have not received recent antibiotics, infections are predominantly monomicrobial (or limited oligomicrobial), caused by Gram-positive cocci:

• Staphylococcus aureus: The single most common virulent pathogen, producing coagulase, enterotoxins, and collagenases that degrade soft tissue.
• Streptococcus species: Primarily Group B Streptococcus (Streptococcus agalactiae), followed by Group A (Streptococcus pyogenes) and Groups C and G.

Chronic, Deep, Limb-Threatening DFIs

In chronic wounds ($> 4$ to 6 weeks duration), deep ulcers probing to tendon or bone, recurrent infections, or limbs with severe ischemia, infections are characteristically polymicrobial (averaging 3 to 5 distinct isolates per specimen) with synergistic aerobic-anaerobic bacterial communities:

• Gram-Positive Cocci: S. aureus, Streptococcus agalactiae, and Enterococcus faecalis.
• Gram-Negative Bacilli (Enterobacterales): Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, and Morganella morganii.
• Obligate Anaerobes: Bacteroides fragilis, Prevotella species, Peptostreptococcus species, and Finegoldia magna. Anaerobes thrive in necrotic, poorly perfused, ischemic tissue and are responsible for tissue gas formation, deep tissue liquefaction, and foul odor.

Specific High-Risk Pathogen Triggers

1. Methicillin-Resistant Staphylococcus aureus (MRSA):
   • Risk Triggers: High local community or institutional MRSA prevalence ($> 30\%$ to $50\%$), prior documented MRSA colonization or infection, recent hospitalization or skilled nursing facility residence within the past 12 months, chronic maintenance hemodialysis, or severe systemic toxicity.
   • Empiric Regimens: Vancomycin, daptomycin, linezolid, or ceftaroline.
2. Pseudomonas aeruginosa:
   • Do not add empiric antipseudomonal therapy for routine diabetic foot infections in a temperate climate merely because an ulcer is macerated, wet, or chronic.
   • Consider empiric coverage when P. aeruginosa was isolated from the affected site within the previous weeks in a moderate or severe infection in an appropriate tropical or subtropical region, then narrow to quality culture results and clinical response.

---

Comparative Summary Table: Microbiological Sampling & Pathogen Profiles

---

Clinical Scenario & Exam Traps

Clinical Scenario: The Unwashed Swab and Antibiotic Escalation

A 58-year-old male with a 6-week-old plantar metatarsal ulcer presents to a wound clinic with mild surrounding cellulitis ($1.5\text{ cm}$ of periwound erythema) and foul odor. The medical assistant opens a sterile cotton swab, swabs the uncleaned yellow slough resting in the wound base, and places it in transport gel. The laboratory report returns: "Heavy growth of Corynebacterium species and Staphylococcus epidermidis; Scant growth of Pseudomonas aeruginosa." The clinician prescribes oral ciprofloxacin and topical silver sulfadiazine.

Two weeks later, the patient presents to the emergency department with a tracking plantar abscess, ascending lymphangitis, and purulent drainage. An urgent deep tissue curettage performed in the operating room following sharp debridement reveals heavy growth of Methicillin-Resistant Staphylococcus aureus (MRSA) and Bacteroides fragilis; Pseudomonas is absent.

Clinical Critique: The initial provider made two critical microbiological errors. First, swabbing an uncleaned ulcer bed recovered surface colonizers (Corynebacterium and S. epidermidis) and an environmental contaminant (Pseudomonas), while missing the true, invasive deep pathogens (MRSA and anaerobes). Second, prescribing ciprofloxacin failed to cover MRSA and obligate anaerobes, allowing the infection to advance into a life-threatening deep plantar phlegmon. Debriding the ulcer bed and obtaining a deep tissue curettage at the initial visit would have isolated the MRSA and anaerobes, resulting in effective culture-directed therapy.